Zobrazeno 1 - 10
of 195
pro vyhledávání: '"C. Strehl"'
Autor:
H.-J. van Alphen, C. Strehl, F. Vollmer, E. Interwies, A. Petersen, S. Görlitz, L. Locatelli, M. Martinez Puentes, M. Guerrero Hidalga, E. Giannakis, T. Spek, M. Scheibel, E. Kristvik, F. Rocha, E. Bergsma
Publikováno v:
Natural Hazards and Earth System Sciences, Vol 21, Pp 2145-2161 (2021)
As Europe is faced with increasing droughts and extreme precipitation, countries are taking measures to adapt to these changes. It is challenging, however, to navigate through the wide range of possible measures, taking into account the efficacy, eco
Externí odkaz:
https://doaj.org/article/b701f5c5f3d94cf49d612d274c755725
Autor:
C. Strehl, M. Wittlich
Publikováno v:
Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie. 71:262-269
Zusammenfassung Hintergrund Tätigkeitsbezogene Daten zur beruflichen und privaten UV-Exposition als Grundlage sowohl für die retrospektive Überprüfung von Kriterien der BK-Nr. 5103, aber auch die prospektive Modellierung anderer möglicher epidem
Publikováno v:
Zeitschrift für Rheumatologie. 78:775-788
Glucocorticoids (GC) have been proven drug substances in rheumatology for more than 70 years. They act very rapidly in high doses through membrane stabilizing effects. Genomic therapeutic effects of GC even in very low doses are mainly due to inhibit
Autor:
Frank Buttgereit, Philipp Mertins, A. Damerau, Aditi Kuppe, C. Strehl, Siska Wilantri, Timo Gaber, Marieluise Kirchner, L. Ehlers
Adenine nucleotides represent crucial immunomodulators in the extracellular environment. The ectonucleotidases CD39 and CD73 are responsible for the sequential catabolism of ATP to adenosine via AMP, thus promoting an anti-inflammatory milieu induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a32411a770e7243642e9724e07ebfdfa
https://doi.org/10.17169/refubium-36825
https://doi.org/10.17169/refubium-36825
[Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases]
Publikováno v:
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 71(2)
Glucocorticoids (GC) have been proven drug substances in rheumatology for more than 70 years. They act very rapidly in high doses through membrane stabilizing effects. Genomic therapeutic effects of GC even in very low doses are mainly due to inhibit
Autor:
R. Schardt, C. Strehl
Publikováno v:
Stahlbau. 87:923-933
Autor:
C. Strehl, Frank Buttgereit, Peggy Schumann, Mathias Mursell, Paula Hoff, M. Hahne, Timo Gaber
Publikováno v:
Microvascular Research. 116:34-44
Hypoxia driven angiogenesis is a prominent feature of tissue regeneration, inflammation and tumor growth and is regulated by hypoxia-inducible factor (HIF)-1 and -2. The distinct functions of HIFs in the hypoxia-induced angiogenesis and metabolic swi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Johannes W. J. Bijlsma, Marlies C van der Goes, Johannes W G Jacobs, Frank Buttgereit, C. Strehl
Publikováno v:
Expert Opinion on Investigational Drugs. 26:187-195
The beneficial effects of glucocorticoids are highly regarded in the treatment of inflammatory diseases. In rheumatoid arthritis, these drugs are widely used because they effectively reduce signs and symptoms of the disease, and exert disease-modifyi
Publikováno v:
Clinical Immunology. 186:64-66
Glucocorticoids are cost-effective drugs with potent anti-inflammatory and immunosuppressive effects. They are used successfully to treat many disorders, including rheumatoid arthritis, polymyalgia rheumatic and other rheumatic diseases. However, the